Nasdaq
TVTX
Travere Therapeutics, Inc.
- Health Care
- 1 day
- −0.5%
- 1 month
- +8.0%
- 1 year
- +262%
$62.45 · Mkt cap $5.89B
At the 6 Aug 2026 close
Nasdaq
Travere Therapeutics, Inc.
$62.45 · Mkt cap $5.89B
At the 6 Aug 2026 close
Travere Therapeutics, Inc. trades under the ticker TVTX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $5.89B. The last closing price was $62.45, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +262%, and +8.0% over the past month. Returns are price returns and exclude dividends.
This page exists because TVTX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.